GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (OTCPK:KHTRF) » Definitions » Loans Receivable

Knight Therapeutics (Knight Therapeutics) Loans Receivable : $0.0 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Loans Receivable?

Knight Therapeutics's Loans Receivable for the quarter that ended in Mar. 2024 was $0.0 Mil.


Knight Therapeutics Loans Receivable Historical Data

The historical data trend for Knight Therapeutics's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics Loans Receivable Chart

Knight Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Knight Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Knight Therapeutics Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Knight Therapeutics Loans Receivable Related Terms

Thank you for viewing the detailed overview of Knight Therapeutics's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Knight Therapeutics (Knight Therapeutics) Business Description

Traded in Other Exchanges
Address
3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Knight Therapeutics (Knight Therapeutics) Headlines

From GuruFocus

3 Ben Graham Value Stocks to Consider as Markets Tumble

By Margaret Moran Margaret Moran 03-04-2020

18 Questions With Todd Massedge

By PJ Pahygiannis PJ Pahygiannis 09-19-2016

Knight to Present at the Jefferies 2021 Virtual Healthcare Conference

By GlobeNewswire GlobeNewswire 05-25-2021